NCT02826005View on ClinicalTrials.gov

Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population.

NAUnknownINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Fibrosis
Interventions
DEVICE

MRI

Sponsors

Lead Sponsor

Ilex Medical
All Listed Sponsors
lead

Ilex Medical

INDUSTRY